24 STOCK AND SELL - MEDICINES & HEALTHCARE PAIN RELIEF The bestselling pain reliever on the market! ‡ On TV in <strong>February</strong> – March Anadin Extra. For Pain Relief. † Based on caffeine absorption data. ‡ Anadin Extra 16s Nielsen 2016 Volume Sales AOA GSL Market. Supply classification: GSL. Keep out of the sight and reach of children. Selected stores only, subject to availability. Further information about these products, including adverse reactions, precautions, contra-indications, and *Trade Mark method of use can be requested from Pfizer Consumer Healthcare Ltd, Walton Oaks, Surrey, KT20 7NS. PP-ANE-GBR-0031 ANADIN PACK SIZE MOQ RSP SSP DISC OUTER COST UP TO 17.5% OFF TRADE Anadin Extra 545mg Tab 12 12 2.22 1.79 17.5% 12.87 ANA0155E 038-6656 Anadin Extra 545mg Tab 16 12 2.77 2.19 17.5% 16.04 ANA0262S 249-0506 Anadin Extra 545mg Tab 32 6 4.12 3.29 17.5% 11.98 ANA0257R 249-0514 Anadin Original 325mg Tab 16 12 2.03 1.59 17.5% 11.74 ANA0261W 249-0456 Anadin Extra Sol 545mg Tab 12 6 3.61 2.89 17.5% 10.94 ANA0362Q 365-6006 Anadin Paracetamol 500mg Tab 16 12 2.03 1.60 12.5% 12.50 ANA0256V 249-0530 LINK PIP
Strong pain relief 1 Gets to work fast Simpler dosage Clinically proven to provide over 30% more pain relief than single active analgesics* NEW PHARMACY ONLY BRAND DOUBLE ACTION PAIN RELIEF WITHOUT OPIATES TV NATIONAL CAMPAIGN TO DRIVE PATIENTS INTO PHARMACY Combogesic (500mg/150mg film coated tablets) Prescribing Information: Presentation: A white capsule with break line on one side and plain on the other side containing Paracetamol 500 mg and Ibuprofen 150 mg. Indications: For temporary relief of pain associated with: headache, migraine, backache, period pain, dental pain, muscular pain, cold and fl u symptoms, sore throat and fever. Dosage and Administration: For oral administration and short term use only. The patient should consult a doctor if the symptoms persist or worsen or if the product is required for more than 3 days. Adults: One to two tablets taken every six hours, as required, up to a maximum of six tablets in 24 hours. Elderly: As the adult dose but with an increased risk of adverse reactions. The lowest effective dose should be used for the shortest possible duration. Children under18 years: Not recommended. Contraindications: In patients with known hypersensitivity reaction to paracetamol, ibuprofen, other NSAIDs or to any of the excipients. Patients with active alcoholism. Asthma, urticaria, previous hypersensitivity to acetylsalicylic acid (aspirin). History of, or current gastrointestinal bleeding or peptic ulceration. Severe heart failure (NYHA Class IV), hepatic failure, renal failure. Cerebrovascular or other active bleeding. Blood-formation disturbances. Hereditary glucose/galactose intolerance/malabsorption. This product should not be taken with other products containing paracetamol, ibuprofen, acetylsalicylic acid, salicylates or with any other anti-infl ammatory medicines unless under a doctor’s instruction. Warnings and Precautions: Use with caution in the elderly and in patients with liver disease, impaired liver function, excess alcohol consumption, renal impairment, dehydration, cardiac impairment, hepatic impairment, coagulation defects, heart failure, GI disease, ulcerative colitis, Crohn’s disease, porphyria, varicella, hypertension, congestive heart failure, heart disease, peripheral arterial disease, cerebrovascular disease, cardiovascular disease, pre-existing asthma, adrenal insuffi ciency, diabetes mellitus and smoking. Caution in patients when also taking ACE inhibiting drugs, NSAID or COX-2 inhibitors, thiazide diuretics, acetylsalicylic acid in prolonged corticosteroid therapy, or anticoagulation therapy. Fertility, Pregnancy and Lactation: Not to be used during the fi rst 6 months of pregnancy or in the third trimester of pregnancy. Breastfeeding can take place during short term treatment. May impair female fertility during use. *Versus paracetamol 1000mg, ibuprofen 200/400mg. † Versus ibuprofen 200/400mg. ‡ Compared to interspersing standard paracetamol and ibuprofen. Reference 1 Merry A, et al. AFT-MX-1. Department of Anaesthesiology, University of Auckland, New Zealand 2008. COMBOGESIC Faster onset of action than maximum <strong>OTC</strong> dose of ibuprofen alone † For more information and to access CPD training visit www.combogesichcp.co.uk Paracetamol DOUBLE ACTION Up to 2 tablets 3 times a day means less risk of under/over dosing ‡ Undesirable Effects: Decrease in haemoglobin and haematocrit, bleeding episodes (e.g. epistaxis, menorrhagia), haematopoietic disorders (agranulocytosis, anaemia, aplastic, anaemia, haemolytic anaemia leucopoenia, neutropenia, pancytopenia, thrombocytopenia), oedema, fl uid retention, palpitations, tachycardia, arrhythmia, cardiac failure, vertigo, tinnitus, amblyopia, abdominal pain, diarrhoea, dyspepsia, nausea, stomach discomfort, vomiting, fl atulence, constipation, peptic ulcer, gastrointestinal haemorrhage, ulcerative stomatitis, ulcerative colitis, Crohn’s disease, fatigue, malaise, abnormal liver function, hepatitis, jaundice, hypersensitivity reactions, skin rash, serum sickness, lupus erythematosus syndrome, Henoch-Schönlein vasculitis, angioedema, liver function test abnormalities, blood creatinine & blood urea increased, blood alkaline phosphate increased, blood creatinine phosphokinease increased, haemoglobin decreased, platelet count increased, hypokalemia, gynaecomastia, hypoglycaemic reaction, dizziness, headache, nervousness, depression, insomnia, confusion, somnolence, aseptic meningitis, paraesthesias, hallucinations, paradoxical stimulation, optic neuritis, psychomotor impairment, tremor, convulsions, urinary retention, interstitial nephritis, nephrotic syndrome, acute and chronic renal failure, adverse renal effects, liver failure, renal disease, thickened respiratory tract secretions, asthma, bronchospasm, dyspnoea, rash, dermatitis, pruritus, hyperhidrosis, purpura, photosensitivity, erythema, multiforme, Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN). Legal Category: P. Pack size: 16 & 32 tablets. Trade Price: 16s: £30.96 (12), 32s: £25.20 (6). MA Number: PL00240/0383. MA Holder: Thornton & Ross Limited, Linthwaite, Huddersfi eld, HD7 5QH. Date of preparation: 30.08.2016 - V01. Information about this product, including adverse reactions, precautions, contra-indications, and the method of use can be found at www.medicines.org.uk Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Medical Information on 0870 851 0207. Ibuprofen Strong, fast acting pain relief without opiates PACK SIZE MOQ RSP SSP DISC OUTER COST Available in pack sizes of 16 and 32 Combogesic 16 16 12 3.99 3.49 12.5% 27.09 COM0797C 400-0295 Ccombogesic 32 32 6 6.49 5.99 12.5% 22.05 COM0798V 400-3011 LINK PIP 25 STOCK AND SELL - MEDICINES & HEALTHCARE PAIN RELIEF 4174 <strong>AAH</strong> Combogesic Plof+FINAL.indd 1 22/12/2016 10:20
Change language